ADDEX THERAPEUTICS LTD
ADXN · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $3.01
- Today’s Low
- $2.98
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.08
- Previous Close
- $3.04
- Volume
- 2.67K
- Market Cap
- $2.73M
- P/E Ratio
- --
- EPS
- $-0.06
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- CHEMIN DES MINES, 9, GENEVA, SWITZERLAND, 1202
- Country
- CH
- Listing Date
- 2007-05-22
- Fiscal Year End
- December
- Shares Outstanding
- 218.65M
- CIK
- 0001574232
- Website
- www.addextherapeutics.com/en
Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland.
Financial Metrics
Revenue
2026-06-30
$9.9K
2026-03-31
$7.69K
2025-12-31
$19.8K
2025-09-30
$29.72K
Operating Expenses
2026-06-30
$627.6K
2026-03-31
$451.38K
2025-12-31
$992.18K
2025-09-30
$725.89K
Net Income
2026-06-30
-$1.73M
2026-03-31
-$1.71M
2025-12-31
-$2.29M
2025-09-30
-$1.57M
Net Profit Margin
2026-06-30
-17.54K%
2026-03-31
-22.25K%
2025-12-31
-11.6K%
2025-09-30
-5.3K%
Earnings Per Share
2026-06-30
$-2.16
2026-03-31
$-1.33
2025-12-31
--
2025-09-30
$-0.01
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$617.69K
2026-03-31
-$1.7M
2025-12-31
-$972.37K
2025-09-30
-$1.57M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $9.9K | $7.69K | $19.8K | $29.72K |
| Operating Expenses | $627.6K | $451.38K | $992.18K | $725.89K |
| Net Income | -$1.73M | -$1.71M | -$2.29M | -$1.57M |
| Net Profit Margin | -17.54K% | -22.25K% | -11.6K% | -5.3K% |
| Earnings Per Share | $-2.16 | $-1.33 | -- | $-0.01 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$617.69K | -$1.7M | -$972.37K | -$1.57M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.